Podcast: ‘over kanker en levenskracht’
Een inkijk in hoofd en hart van sleutelfiguren uit de oncologie. We stellen jullie graag onze nieuwe podcastreeks ‘Over kanker en levenskracht‘ voor. …
HIV
Hepatitis B/C
Dr. Sanne De Smet, UZgent
Dr. Marie-Angélique De Scheerder, UZgent
References:
1. Cook, Michael R., and Chul Kim. “Safety and efficacy of immune checkpoint inhibitor therapy in patients with HIV infection and advanced-stage cancer: a systematic review.” JAMA oncology 5.7 (2019): 1049-1054.
2. Spano, Jean-Philippe, et al. “Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience.” Aids 33.11 (2019): F13-F19.
3. Uldrick, Thomas S., et al. “Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer—a phase 1 study.” JAMA oncology 5.9 (2019): 1332-1339.
4. Navarro, Alejandro, Alex Martinez-Marti, and Enriqueta Felip. “HIV-positive patients with lung cancer: is immunotherapy a safe and active option for them?.” Journal of Thoracic Oncology 13.7 (2018): 874-876.
5. Heppt, M. V., et al. “Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients.” Annals of Oncology 28.12 (2017): 3104-3106.
6. Tio, Martin, et al. “Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection.” European Journal of Cancer 104 (2018): 137-144.
7. Sangro, Bruno, et al. “A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.” Journal of Hepatology 59.1 (2013): 81-88.
8. Boyer, Zoe, and Sarah Palmer. “Targeting immune checkpoint molecules to eliminate latent HIV.” Frontiers in immunology 9 (2018): 2339.
Een inkijk in hoofd en hart van sleutelfiguren uit de oncologie. We stellen jullie graag onze nieuwe podcastreeks ‘Over kanker en levenskracht‘ voor. …
Precision intiative “Two ongoing comprehensive genomic profiling studies from BSMO: GeNeo and BALLETT” We are proud to present our ongoing …
Recent is er een ABCIP platform o.l.v. Frederic Amant, dewelke kan geraadpleegd worden door collega’s i.g.v. kanker tijdens zwangerschap. Bij …